Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by J-Y Douillard
Cediranib With mFOLFOX6 vs Bevacizumab With mFOLFOX6 in Previously Treated Metastatic Colorectal Cancer
British Journal of Cancer
Cancer Research
Oncology
Phase II Study of Nitrosourea Fotemustine as Single-Drug Chemotherapy in Poor-Prognosis Non-Small-Cell Lung Cancer
British Journal of Cancer
Cancer Research
Oncology
Related publications
Hypertension and Overall Survival in Metastatic Colorectal Cancer Patients Treated With Bevacizumab-Containing Chemotherapy
British Journal of Cancer
Cancer Research
Oncology
A Rare Case of Pathologically Complete Response of Locally Advanced Colorectal Cancer After Systemic Chemotherapy With mFOLFOX6
Nippon Daicho Komonbyo Gakkai Zasshi
The Clinical Benefit of Bevacizumab in Metastatic Colorectal Cancer Is Independent of K-Ras Mutation Status: Analysis of a Phase III Study of Bevacizumab With Chemotherapy in Previously Untreated Metastatic Colorectal Cancer
Oncologist
Cancer Research
Medicine
Oncology
A Phase I Study of Intravenous Aflibercept With FOLFIRI in Japanese Patients With Previously Treated Metastatic Colorectal Cancer
Investigational New Drugs
Oncology
Pharmacology
Adverse Events Associated With Bevacizumab and Chemotherapy in Older Patients With Metastatic Colorectal Cancer
Clinical Colorectal Cancer
Oncology
Gastroenterology
Phase II Study of Gefitinib, Fluorouracil, Leucovorin, and Oxaliplatin Therapy in Previously Treated Patients With Metastatic Colorectal Cancer
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Perioperative Chemotherapy With or Without Bevacizumab in Patients With Metastatic Colorectal Cancer Undergoing Liver Resection
Clinical Colorectal Cancer
Oncology
Gastroenterology
Correlation of Lactate Dehydrogenase Isoenzyme Profile With Outcome in Patients With Advanced Colorectal Cancer Treated With Chemotherapy and Bevacizumab or Cediranib: Retrospective Analysis of the HORIZON I Study
Clinical Colorectal Cancer
Oncology
Gastroenterology
Prognostic/Predictive Value of 207 Serum Factors in Colorectal Cancer Treated With Cediranib and/or Chemotherapy
British Journal of Cancer
Cancer Research
Oncology
